The role of particle-mediated DNA vaccines in biodefense preparedness

Advanced Drug Delivery Reviews

Volumn 57, Issue 9, 2005, Pages 1315-1342

  Dean, Hansi J ^a,c   Haynes, Joel ^a   Schmaljohn, Connie ^b  

^a PowderJect Vaccines Inc   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c NONE   (United States)

Author keywords

Biodefense; Dengue; DNA vaccine; Ebola; Epidermis; Gene gun; Hantavirus; Marburg; Smallpox; Tick borne encephalitis; Venezuelan equine encephalitis

Indexed keywords

ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; BIOTECHNOLOGY; COATINGS; CYTOLOGY; DNA; GENES; GOLD; IMMUNIZATION; VIRUSES;

BIODEFENSE; DNA DELIVERY; DNA VACCINES; PARTICLE-MEDIATED EPIDERMAL DELIVERY (PMED);

VACCINES;

ADENOVIRUS VECTOR; ALPHAVIRUS VACCINE; ANTIGEN; APOPTOSIS INDUCING FACTOR; BACTERIAL TOXIN; CALRETICULIN; CENTRAL EUROPEAN ENCEPHALITIS VIRUS VACCINE; CHEMOKINE; CHOLERA TOXIN; CYTOKINE; DENDRITIC CELL VACCINE; DENGUE VACCINE; DNA; DNA VACCINE; EBOLA VACCINE; ESCHERICHIA COLI ENTEROTOXIN; FILOVIRUS VACCINE; FLAVIVIRUS VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HANTAVIRUS VACCINE; HEAT SHOCK PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; IMMUNOSTIMULATING AGENT; INTERLEUKIN 12; MALARIA VACCINE; MARBURG VIRUS VACCINE; NEUTRALIZING ANTIBODY; POXVIRUS VACCINE; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; SMALLPOX VACCINE; SPRING SUMMER ENCEPHALITIS VIRUS VACCINE; TICK BORNE ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG; VENEZUELAN ENCEPHALITIS VIRUS VACCINE; VIRUS GLYCOPROTEIN; VIRUS NUCLEOPROTEIN; VIRUS VACCINE; VIRUS VECTOR;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; BACULOVIRUS EXPRESSION SYSTEM; BUNYAVIRUS; CELL COUNT; CELL NUCLEUS; CELLULAR IMMUNITY; CLINICAL TRIAL; CPG ISLAND; CROSS PRESENTATION; CYTOPLASM; DENGUE; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; EBOLA VIRUS; ENCEPHALITIS; ENCEPHALOMYELITIS; EPIDERMIS; FLAVIVIRUS; GENE EXPRESSION; GENE FUSION; GENE GUN; GENE TARGETING; GENETIC ENGINEERING; GENETIC TRANSFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; INTERMETHOD COMPARISON; KERATINOCYTE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; POLARIZATION; POXVIRUS; PRIMATE; PRIORITY JOURNAL; PUBLIC HEALTH; REPLICON; REVIEW; RODENT; SKIN; SMALLPOX; TICK BORNE ENCEPHALITIS; TOGAVIRUS; VACCINATION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRAL GENE DELIVERY SYSTEM; VIREMIA; VIRUS HEMORRHAGIC FEVER; VIRUS RECOMBINANT; VIRUS VIRULENCE;

ADMINISTRATION, CUTANEOUS; ANIMALS; BIOLOGICAL WARFARE; DNA, VIRAL; DRUG DELIVERY SYSTEMS; HUMANS; VIRAL VACCINES; VIRUS DISEASES;

EID: 20344397680     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2005.01.012     Document Type: Review

References (202)

1. L.D. Rotz, A.S. Khan, S.R. Lillibridge, S.M. Ostroff, and J.M. Hughes Public health assessment of potential biological terrorism agents Emerg. Infect. Dis. 8 2002 225 230
2. P. Christou, D.E. McCabe, and W.F. Swain Stable transformation of soybean callus by DNA-coated gold particles Plant Physiol. 87 1988 671 674
3. R.M. Klein, E.D. Wolf, R. Wu, and J.C. Sanford High-velocity microprojectiles for delivering nucleic acids into living cells. 1987 Biotechnology 24 1992 384 386
4. J.C. Sanford The biolistic process Trends Biotech. 6 1988 299 302
5. S. Fitzpatrick-McElligott Gene transfer to tumor-infiltrating lymphocytes and other mammalian somatic cells by microprojectile bombardment Biotechnology (NY) 10 1992 1036 1040
6. R.S. Williams, S.A. Johnston, M. Riedy, M.J. DeVit, S.G. McElligott, and J.C. Sanford Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles Proc. Natl. Acad. Sci. U. S. A. 88 1991 2726 2730
7. N.S. Yang, J. Burkholder, B. Roberts, B. Martinell, and D. McCabe In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment Proc. Natl. Acad. Sci. U. S. A. 87 1990 9568 9572
8. D.C. Tang, M. DeVit, and S.A. Johnston Genetic immunization is a simple method for eliciting an immune response Nature 356 1992 152 154
9. J.R. Haynes, D.H. Fuller, D. McCabe, W.F. Swain, and G. Widera Induction and characterization of humoral and cellular immune responses elicited via gene gun-mediated nucleic acid immunization Adv. Drug Deliv. Rev. 21 1996 3 18
10. L.G. Payne, D.H. Fuller, and J.R. Haynes Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogma Curr. Opin. Mol. Ther. 4 2002 459 466
11. M.J. McCluskie, C.L. Brazolot Millan, R.A. Gramzinski, H.L. Robinson, J.C. Santoro, J.T. Fuller, G. Widera, J.R. Haynes, R.H. Purcell, and H.L. Davis Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates Mol. Med. 5 1999 287 300
12. E.F. Fynan, R.G. Webster, D.H. Fuller, J.R. Haynes, J.C. Santoro, and H.L. Robinson DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations Proc. Natl. Acad. Sci. U. S. A. 90 1993 11478 11482
13. T.M. Pertmer, M.D. Eisenbraun, D. McCabe, S.K. Prayaga, D.H. Fuller, and J.R. Haynes Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA Vaccine 13 1995 1427 1430
14. A. Yoshida, T. Nagata, M. Uchijima, T. Higashi, and Y. Koide Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses Vaccine 18 2000 1725 1729
15. M.D. Eisenbraun, D.H. Fuller, and J.R. Haynes Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization DNA Cell Biol. 12 1993 791 797
16. L. Benvenisti, A. Rogel, L. Kuznetzova, S. Bujanover, Y. Becker, and Y. Stram Gene gun-mediate DNA vaccination against foot-and-mouth disease virus Vaccine 19 2001 3885 3895
17. D.H. Fuller, P.A. Rajakumar, L.A. Wilson, A.M. Trichel, J.T. Fuller, T. Shipley, M.S. Wu, K. Weis, C.R. Rinaldo, J.R. Haynes, and M. Murphey-Corb Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine J. Virol. 76 2002 3309 3317
18. M.D. Macklin, D. McCabe, M.W. McGregor, V. Neumann, T. Meyer, R. Callan, V.S. Hinshaw, and W.F. Swain Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus J. Virol. 72 1998 1491 1496
19. J.T. Fuller, D.H. Fuller, D. McCabe, J.R. Haynes, and G. Widera Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization Ann. N.Y. Acad. Sci. 772 1995 282 284
20. R.R. MacGregor, J.D. Boyer, R.B. Ciccarelli, R.S. Ginsberg, and D.B. Weiner Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: follow-up data J. Infect. Dis. 181 2000 406
21. J.D. Boyer, A.D. Cohen, S. Vogt, K. Schumann, B. Nath, L. Ahn, K. Lacy, M.L. Bagarazzi, T.J. Higgins, Y. Baine, R.B. Ciccarelli, R.S. Ginsberg, R.R. MacGregor, and D.B. Weiner Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines J. Infect. Dis. 181 2000 476 483
22. R. Wang, D.L. Doolan, T.P. Le, R.C. Hedstrom, K.M. Coonan, Y. Charoenvit, T.R. Jones, P. Hobart, M. Margalith, J. Ng, W.R. Weiss, M. Sedegah, C. de Taisne, J.A. Norman, and S.L. Hoffman Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine Science 282 1998 476 480
23. R. Wang, J. Epstein, F.M. Baraceros, E.J. Gorak, Y. Charoenvit, D.J. Carucci, R.C. Hedstrom, N. Rahardjo, T. Gay, P. Hobart, R. Stout, T.R. Jones, T.L. Richie, S.E. Parker, D.L. Doolan, J. Norman, and S.L. Hoffman Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine Proc. Natl. Acad. Sci. U. S. A. 98 2001 10817 10822
24. T.P. Le, K.M. Coonan, R.C. Hedstrom, Y. Charoenvit, M. Sedegah, J.E. Epstein, S. Kumar, R. Wang, D.L. Doolan, J.D. Maguire, S.E. Parker, P. Hobart, J. Norman, and S.L. Hoffman Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers Vaccine 18 2000 1893 1901
25. R.R. MacGregor, J.D. Boyer, K.E. Ugen, K.E. Lacy, S.J. Gluckman, M.L. Bagarazzi, M.A. Chattergoon, Y. Baine, T.J. Higgins, R.B. Ciccarelli, L.R. Coney, R.S. Ginsberg, and D.B. Weiner First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response J. Infect. Dis. 178 1998 92 100
26. K.E. Ugen, S.B. Nyland, J.D. Boyer, C. Vidal, L. Lera, S. Rasheid, M. Chattergoon, M.L. Bagarazzi, R. Ciccarelli, T. Higgins, Y. Baine, R. Ginsberg, R.R. Macgregor, and D.B. Weiner DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans Vaccine 16 1998 1818 1821
27. J.D. Boyer, M.A. Chattergoon, K.E. Ugen, A. Shah, M. Bennett, A. Cohen, S. Nyland, K.E. Lacy, M.L. Bagarazzi, T.J. Higgins, Y. Baine, R.B. Ciccarelli, R.S. Ginsberg, R.R. MacGregor, and D.B. Weiner Enhancement of cellular immune response in HIV-1 seropositive individuals: a DNA-based trial Clin. Immunol. 90 1999 100 107
28. R.R. MacGregor, R. Ginsberg, K.E. Ugen, Y. Baine, C.U. Kang, X.M. Tu, T. Higgins, D.B. Weiner, and J.D. Boyer T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev Aids 16 2002 2137 2143
29. M.J. Roy, M.S. Wu, L.J. Barr, J.T. Fuller, L.G. Tussey, S. Speller, J. Culp, J.K. Burkholder, W.F. Swain, R.M. Dixon, G. Widera, R. Vessey, A. King, G. Ogg, A. Gallimore, J.R. Haynes, and D. Heydenburg Fuller Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine Vaccine 19 2000 764 778
30. S.T. Rottinghaus, G.A. Poland, R.M. Jacobson, L.J. Barr, and M.J. Roy Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination Vaccine 21 2003 4604 4608
31. J. Riemenschneider, A. Garrison, J. Geisbert, P. Jahrling, M. Hevey, D. Negley, A. Schmaljohn, J. Lee, M.K. Hart, L. Vanderzanden, D. Custer, M. Bray, A. Ruff, B. Ivins, A. Bassett, C. Rossi, and C. Schmaljohn Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus Vaccine 21 2003 4071 4080
32. C.P. Locher, K.F. Sykes, D.J. Blackbourn, and S.A. Johnston Immune responses in baboons vaccinated with HIV-2 genetic expression libraries J. Med. Primatol. 31 2002 323 329
33. M.A. Barry, W.C. Lai, and S.A. Johnston Protection against mycoplasma infection using expression-library immunization Nature 377 1995 632 635
34. K.F. Sykes, M.G. Lewis, B. Squires, and S.A. Johnston Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge Vaccine 20 2002 2382 2395
35. S.A. Johnston, B.X. Qu, M. McGuire, K. Stemke-Hale, and K. Sykes Applications of, and future challenges for, genetic vaccines Dev. Biol. (Basel) 104 2000 3 8
36. S.A. Johnston, and M.A. Barry Genetic to genomic vaccination Vaccine 15 1997 808 809
37. F.D. Ivey, D.M. Magee, M.D. Woitaske, S.A. Johnston, and R.A. Cox Identification of a protective antigen of Coccidioides immitis by expression library immunization Vaccine 21 2003 4359 4367
38. C. Condon, S.C. Watkins, C.M. Celluzzi, K. Thompson, and L.D. Falo Jr. DNA-based immunization by in vivo transfection of dendritic cells Nat. Med. 2 1996 1122 1128
39. C.M. Boyle, and H.L. Robinson Basic mechanisms of DNA-raised antibody responses to intramuscular and gene gun immunizations DNA Cell Biol. 19 2000 157 165
40. A. Porgador, K.R. Irvine, A. Iwasaki, B.H. Barber, N.P. Restifo, and R.N. Germain Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization J. Exp. Med. 188 1998 1075 1082
41. A.T. Larregina, S.C. Watkins, G. Erdos, L.A. Spencer, W.J. Storkus, D. Beer Stolz, and L.D. Falo Jr. Direct transfection and activation of human cutaneous dendritic cells Gene Ther. 8 2001 608 617
42. L. Timares, K.M. Safer, B. Qu, A. Takashima, and S.A. Johnston Drug-inducible, dendritic cell-based genetic immunization J. Immunol. 170 2003 5483 5490
43. K.E. Steele, K. Stabler, and L. VanderZanden Cutaneous DNA vaccination against Ebola virus by particle bombardment: histopathology and alteration of CD3-positive dendritic epidermal cells Vet. Pathol. 38 2001 203 215
44. A. Iwasaki, C.A. Torres, P.S. Ohashi, H.L. Robinson, and B.H. Barber The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites J. Immunol. 159 1997 11 14
45. D.M. Klinman, J.M. Sechler, J. Conover, M. Gu, and A.S. Rosenberg Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory J. Immunol. 160 1998 2388 2392
46. C.A. Torres, A. Iwasaki, B.H. Barber, and H.L. Robinson Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations J. Immunol. 158 1997 4529 4532
47. J.H. Cho, J.W. Youn, and Y.C. Sung Cross-priming as a predominant mechanism for inducing CD8(+) T cell responses in gene gun DNA immunization J. Immunol. 167 2001 5549 5557
48. L. Timares, A. Takashima, and S.A. Johnston Quantitative analysis of the immunopotency of genetically transfected dendritic cells Proc. Natl. Acad. Sci. U. S. A. 95 1998 13147 13152
49. S. Garg, A. Oran, J. Wajchman, S. Sasaki, C.H. Maris, J.A. Kapp, and J. Jacob Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo Nat. Immunol. 4 2003 907 912
50. D.M. Feltquate, S. Heaney, R.G. Webster, and H.L. Robinson Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization J. Immunol. 158 1997 2278 2284
51. T.M. Pertmer, T.R. Roberts, and J.R. Haynes Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery J. Virol. 70 1996 6119 6125
52. A.E. Oran, and H.L. Robinson DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells J. Immunol. 171 2003 1999 2005
53. P.A. Morel, D. Falkner, J. Plowey, A.T. Larregina, and L.D. Falo DNA immunisation: altering the cellular localisation of expressed protein and the immunisation route allows manipulation of the immune response Vaccine 22 2004 447 456
54. W.W. Leitner, M.C. Seguin, W.R. Ballou, J.P. Seitz, A.M. Schultz, M.J. Sheehy, and J.A. Lyon Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites J. Immunol. 159 1997 6112 6119
55. L. Frelin, M. Alheim, A. Chen, J. Soderholm, B. Rozell, C. Barnfield, P. Liljestrom, and M. Sallberg Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo Gene Ther. 10 2003 686 699
56. C. Trimble, C.T. Lin, C.F. Hung, S. Pai, J. Juang, L. He, M. Gillison, D. Pardoll, L. Wu, and T.C. Wu Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe Vaccine 21 2003 4036 4042
57. S.J. Kent, A. Zhao, S.J. Best, J.D. Chandler, D.B. Boyle, and I.A. Ramshaw Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus J. Virol. 72 1998 10180 10188
58. H. Horton, T.U. Vogel, D.K. Carter, K. Vielhuber, D.H. Fuller, T. Shipley, J.T. Fuller, K.J. Kunstman, G. Sutter, D.C. Montefiori, V. Erfle, R.C. Desrosiers, N. Wilson, L.J. Picker, S.M. Wolinsky, C. Wang, D.B. Allison, and D.I. Watkins Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239 J. Virol. 76 2002 7187 7202
59. T.M. Allen, T.U. Vogel, D.H. Fuller, B.R. Mothe, S. Steffen, J.E. Boyson, T. Shipley, J. Fuller, T. Hanke, A. Sette, J.D. Altman, B. Moss, A.J. McMichael, and D.I. Watkins Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen J. Immunol. 164 2000 4968 4978
60. T. Hanke, V.C. Neumann, T.J. Blanchard, P. Sweeney, A.V. Hill, G.L. Smith, and A. McMichael Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime Vaccine 17 1999 589 596
61. S.K. Prayaga, M.J. Ford, and J.R. Haynes Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization Vaccine 15 1997 1349 1352
62. D.H. Fuller, M.M. Corb, S. Barnett, K. Steimer, and J.R. Haynes Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques Vaccine 15 1997 924 926
63. D.H. Fuller, M. Murphey-Corb, J. Clements, S. Barnett, and J.R. Haynes Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination J. Med. Primatol. 25 1996 236 241
64. N.J. Sullivan, A. Sanchez, P.E. Rollin, Z.Y. Yang, and G.J. Nabel Development of a preventive vaccine for Ebola virus infection in primates Nature 408 2000 605 609
65. L. Vanderzanden, M. Bray, D. Fuller, T. Roberts, D. Custer, K. Spik, P. Jahrling, J. Huggins, A. Schmaljohn, and C. Schmaljohn DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge Virology 246 1998 134 144
66. L. Xu, A. Sanchez, Z. Yang, S.R. Zaki, E.G. Nabel, S.T. Nichol, and G.J. Nabel Immunization for Ebola virus infection Nat. Med. 4 1998 37 42
67. R. Putnak, J. Fuller, L. VanderZanden, B.L. Innis, and D.W. Vaughn Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes Am. J. Trop. Med. Hyg. 68 2003 469 476
68. D.M. Klinman CpG DNA as a vaccine adjuvant Expert Rev. Vaccines 2 2003 305 315
69. A.M. Krieg CpG motifs: the active ingredient in bacterial extracts? Nat. Med. 9 2003 831 835
70. Y. Sato, M. Roman, H. Tighe, D. Lee, M. Corr, M.D. Nguyen, G.J. Silverman, M. Lotz, D.A. Carson, and E. Raz Immunostimulatory DNA sequences necessary for effective intradermal gene immunization Science 273 1996 352 354
71. S. Zelenay, F. Elias, and J. Flo Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides Eur. J. Immunol. 33 2003 1382 1392
72. X. Ma, X. Forns, R. Gutierrez, I.K. Mushahwar, T. Wu, P.J. Payette, J. Bukh, R.H. Purcell, and H.L. Davis DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice Vaccine 20 2002 3263 3271
73. Y. Kojima, K.Q. Xin, T. Ooki, K. Hamajima, T. Oikawa, K. Shinoda, T. Ozaki, Y. Hoshino, N. Jounai, M. Nakazawa, D. Klinman, and K. Okuda Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine Vaccine 20 2002 2857 2865
74. D.M. Feltquate, and H.L. Robinson Effect of CpG methylation on isotype and magnitude of antibody responses to influenza hemagglutinin-expressing plasmid DNA Cell Biol. 18 1999 663 670
75. R. Schirmbeck, and J. Reimann Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12 Intervirology 44 2001 115 123
76. X. Zhou, L. Zheng, L. Liu, L. Xiang, and Z. Yuan T helper 2 immunity to hepatitis B surface antigen primed by gene-gun-mediated DNA vaccination can be shifted towards T helper 1 immunity by codelivery of CpG motif-containing oligodeoxynucleotides Scand. J. Immunol. 58 2003 350 357
77. R. Weiss, S. Scheiblhofer, J. Freund, F. Ferreira, I. Livey, and J. Thalhamer Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines Vaccine 20 2002 3148 3154
78. M.S. Kruskall, C.A. Alper, Z. Awdeh, E.J. Yunis, and D. Marcus-Bagley The immune response to hepatitis B vaccine in humans: inheritance patterns in families J. Exp. Med. 175 1992 495 502
79. M. Salazar, H. Deulofeut, C. Granja, R. Deulofeut, D.E. Yunis, D. Marcus-Bagley, Z. Awdeh, C.A. Alper, and E.J. Yunis Normal HBsAg presentation and T-cell defect in the immune response of nonresponders Immunogenetics 41 1995 366 374
80. I. Desombere, P. Hauser, R. Rossau, J. Paradijs, and G. Leroux-Roels Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes J. Immunol. 154 1995 520 529
81. M.G. Chedid, H. Deulofeut, D.E. Yunis, M.L. Lara-Marquez, M. Salazar, R. Deulofeut, Z. Awdeh, C.A. Alper, and E.J. Yunis Defect in Th1-like cells of nonresponders to hepatitis B vaccine Hum. Immunol. 58 1997 42 51
82. R. Schirmbeck, W. Bohm, K. Ando, F.V. Chisari, and J. Reimann Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice J. Virol. 69 1995 5929 5934
83. S.J. McConkey, W.H. Reece, V.S. Moorthy, D. Webster, S. Dunachie, G. Butcher, J.M. Vuola, T.J. Blanchard, P. Gothard, K. Watkins, C.M. Hannan, S. Everaere, K. Brown, K.E. Kester, J. Cummings, J. Williams, D.G. Heppner, A. Pathan, K. Flanagan, N. Arulanantham, M.T. Roberts, M. Roy, G.L. Smith, J. Schneider, T. Peto, R.E. Sinden, S.C. Gilbert, and A.V. Hill Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans Nat. Med. 9 2003 729 735
84. T. Sakai, H. Hisaeda, Y. Nakano, M. Zhang, M. Takashima, K. Ishii, Y. Maekawa, S. Matsumoto, Y. Nitta, J. Miyazaki, S. Yamamoto, and K. Himeno Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A/J mice Vaccine 21 2003 1432 1444
85. C.M. Leutenegger, F.S. Boretti, C.N. Mislin, J.N. Flynn, M. Schroff, A. Habel, C. Junghans, S.A. Koenig-Merediz, B. Sigrist, A. Aubert, N.C. Pedersen, B. Wittig, and H. Lutz Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif J. Virol. 74 2000 10447 10457
86. F. Siegel, M. Lu, and M. Roggendorf Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection J. Virol. 75 2001 5036 5042
87. R.M. Conry, G. Widera, A.F. LoBuglio, J.T. Fuller, S.E. Moore, D.L. Barlow, J. Turner, N.S. Yang, and D.T. Curiel Selected strategies to augment polynucleotide immunization Gene Ther. 3 1996 67 74
88. S. Sasaki, R.R. Amara, W.S. Yeow, P.M. Pitha, and H.L. Robinson Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors J. Virol. 76 2002 6652 6659
89. J. Arrington, R.P. Braun, L. Dong, D.H. Fuller, M.D. Macklin, S.W. Umlauf, S.J. Wagner, M.S. Wu, L.G. Payne, and J.R. Haynes Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines J. Virol. 76 2002 4536 4546
90. M. Pizza, M.M. Giuliani, M.R. Fontana, E. Monaci, G. Douce, G. Dougan, K.H. Mills, R. Rappuoli, and G. Del Giudice Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants Vaccine 19 2001 2534 2541
91. S. Sasaki, R.R. Amara, A.E. Oran, J.M. Smith, and H.L. Robinson Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases Nat. Biotechnol. 19 1999 543 547
92. S. Sasaki, K.Q. Xin, K. Okudela, K. Okuda, and N. Ishii Immunomodulation by apoptosis-inducing caspases for an influenza DNA vaccine delivered by gene gun Gene Ther. 9 2002 828 831
93. N.P. Restifo Vaccines to die for Nat. Biotechnol. 19 2001 527 528
94. W.W. Leitner, L.N. Hwang, M.J. deVeer, A. Zhou, R.H. Silverman, B.R. Williams, T.W. Dubensky, H. Ying, and N.P. Restifo Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways Nat. Med. 9 2003 33 39
95. T.W. Kim, C.F. Hung, M. Ling, J. Juang, L. He, J.M. Hardwick, S. Kumar, and T.C. Wu Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins J. Clin. Invest. 112 2003 109 117
96. H. Ji, T.L. Wang, C.H. Chen, S.I. Pai, C.F. Hung, K.Y. Lin, R.J. Kurman, D.M. Pardoll, and T.C. Wu Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors Hum. Gene Ther. 10 1999 2727 2740
97. T.W. Kim, C.F. Hung, D. Boyd, J. Juang, L. He, J.W. Kim, J.M. Hardwick, and T.C. Wu Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies J. Immunol. 171 2003 2970 2976
98. C.H. Chen, T.L. Wang, C.F. Hung, Y. Yang, R.A. Young, D.M. Pardoll, and T.C. Wu Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene Cancer Res. 60 2000 1035 1042
99. C.F. Hung, W.F. Cheng, K.F. Hsu, C.Y. Chai, L. He, M. Ling, and T.C. Wu Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen Cancer Res. 61 2001 3698 3703
100. W.F. Cheng, C.F. Hung, C.Y. Chai, K.F. Hsu, L. He, M. Ling, and T.C. Wu Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen J. Clin. Invest. 108 2001 669 678
101. B.P. Nayak, G. Sailaja, and A.M. Jabbar Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4 J. Virol. 77 2003 10850 10861
102. M. Tachedjian, J.S. Boyle, A.M. Lew, B. Horvatic, J.P. Scheerlinck, J.M. Tennent, and M.E. Andrew Gene gun immunization in a preclinical model is enhanced by B7 targeting Vaccine 21 2003 2900 2905
103. C.F. Hung, W.F. Cheng, C.Y. Chai, K.F. Hsu, L. He, M. Ling, and T.C. Wu Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen J. Immunol. 166 2001 5733 5740
104. C.F. Hung, L. He, J. Juang, T.J. Lin, M. Ling, and T.C. Wu Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen J. Virol. 76 2002 2676 2682
105. S.W. Barnett, S. Rajasekar, H. Legg, B. Doe, D.H. Fuller, J.R. Haynes, C.M. Walker, and K.S. Steimer Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit Vaccine 15 1997 869 873
106. D.H. Fuller, L. Simpson, K.S. Cole, J.E. Clements, D.L. Panicali, R.C. Montelaro, M. Murphey-Corb, and J.R. Haynes Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV Immunol. Cell Biol. 75 1997 389 396
107. A.J. Ramsay, K.H. Leong, and I.A. Ramshaw DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors Immunol. Cell Biol. 75 1997 382 388
108. J. Schneider, S.C. Gilbert, C.M. Hannan, P. Degano, E. Prieur, E.G. Sheu, M. Plebanski, and A.V. Hill Induction of CD8+ T cells using heterologous prime-boost immunisation strategies Immunol. Rev. 170 1999 29 38
109. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S.P. O'Neil, S.I. Staprans, D.C. Montefiori, Y. Xu, J.G. Herndon, L.S. Wyatt, M.A. Candido, N.L. Kozyr, P.L. Earl, J.M. Smith, H.L. Ma, B.D. Grimm, M.L. Hulsey, J. Miller, H.M. McClure, J.M. McNicholl, B. Moss, and H.L. Robinson Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 292 2001 69 74
110. J.W. Shiver, T.M. Fu, L. Chen, D.R. Casimiro, M.E. Davies, R.K. Evans, Z.Q. Zhang, A.J. Simon, W.L. Trigona, S.A. Dubey, L. Huang, V.A. Harris, R.S. Long, X. Liang, L. Handt, W.A. Schleif, L. Zhu, D.C. Freed, N.V. Persaud, L. Guan, K.S. Punt, A. Tang, M. Chen, K.A. Wilson, K.B. Collins, G.J. Heidecker, V.R. Fernandez, H.C. Perry, J.G. Joyce, K.M. Grimm, J.C. Cook, P.M. Keller, D.S. Kresock, H. Mach, R.D. Troutman, L.A. Isopi, D.M. Williams, Z. Xu, K.E. Bohannon, D.B. Volkin, D.C. Montefiori, A. Miura, G.R. Krivulka, M.A. Lifton, M.J. Kuroda, J.E. Schmitz, N.L. Letvin, M.J. Caulfield, A.J. Bett, R. Youil, D.C. Kaslow, and E.A. Emini Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature 415 2002 331 335
111. J. Schneider, S.C. Gilbert, T.J. Blanchard, T. Hanke, K.J. Robson, C.M. Hannan, M. Becker, R. Sinden, G.L. Smith, and A.V. Hill Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara Nat. Med. 4 1998 397 402
112. H. McShane, R. Brookes, S.C. Gilbert, and A.V. Hill Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis Infect. Immun. 69 2001 681 686
113. K.R. Irvine, R.S. Chamberlain, E.P. Shulman, D.R. Surman, S.A. Rosenberg, and N.P. Restifo Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors J. Natl. Cancer Inst. 89 1997 1595 1601
114. R.R. Amara, F. Villinger, S.I. Staprans, J.D. Altman, D.C. Montefiori, N.L. Kozyr, Y. Xu, L.S. Wyatt, P.L. Earl, J.G. Herndon, H.M. McClure, B. Moss, and H.L. Robinson Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines J. Virol. 76 2002 7625 7631
115. H.L. Robinson, D.C. Montefiori, R.P. Johnson, K.H. Manson, M.L. Kalish, J.D. Lifson, T.A. Rizvi, S. Lu, S.L. Hu, G.P. Mazzara, D.L. Panicali, J.G. Herndon, R. Glickman, M.A. Candido, S.L. Lydy, M.S. Wyand, and H.M. McClure Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations Nat. Med. 5 1999 526 534
116. N.A. Doria-Rose, C.C. Pierce, M.T. Hensel, W.F. Sutton, N. Sheikh, P. Polacino, L. Kuller, Y.D. Zhu, S.L. Hu, D. Anderson, and N.L. Haigwood Multigene DNA prime-boost vaccines for SHIV89.6P J. Med. Primatol. 32 2003 218 228
117. T. Hanke, and A. McMichael Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS Immunol. Lett. 66 1999 177 181
118. P. Degano, J. Schneider, C.M. Hannan, S.C. Gilbert, and A.V. Hill Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models Vaccine 18 1999 623 632
119. M. Hevey, D. Negley, P. Pushko, J. Smith, and A. Schmaljohn Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates Virology 251 1998 28 37
120. N.J. Sullivan, T.W. Geisbert, J.B. Geisbert, L. Xu, Z.Y. Yang, M. Roederer, R.A. Koup, P.B. Jahrling, and G.J. Nabel Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates Nature 424 2003 681 684
121. A. Sanchez, M.P. Kiley, B.P. Holloway, and D.D. Auperin Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus Virus Res. 29 1993 215 240
122. H. Feldmann, E. Muhlberger, A. Randolf, C. Will, M.P. Kiley, A. Sanchez, and H.D. Klenk Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle Virus Res. 24 1992 1 19
123. M.K. Hart Vaccine research efforts for filoviruses Int. J. Parasitol. 33 2003 583 595
124. T.W. Geisbert, P. Pushko, K. Anderson, J. Smith, K.J. Davis, and P.B. Jahrling Evaluation in nonhuman primates of vaccines against Ebola virus Emerg. Infect. Dis. 8 2002 503 507
125. J.A. Wilson, C.M. Bosio, and M.K. Hart Ebola virus: the search for vaccines and treatments Cell. Mol. Life Sci. 58 2001 1826 1841
126. A. Sanchez, S.G. Trappier, B.W. Mahy, C.J. Peters, and S.T. Nichol The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing Proc. Natl. Acad. Sci. U. S. A. 93 1996 3602 3607
127. V.E. Volchkov, V.A. Volchkova, E. Muhlberger, L.V. Kolesnikova, M. Weik, O. Dolnik, and H.D. Klenk Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity Science 291 2001 1965 1969
128. M. Hevey, D. Negley, L. VanderZanden, R.F. Tammariello, J. Geisbert, C. Schmaljohn, J.F. Smith, P.B. Jahrling, and A.L. Schmaljohn Marburg virus vaccines: comparing classical and new approaches Vaccine 20 2002 586 593
129. J.L. Mellquist-Riemenschneider, A.R. Garrison, J.B. Geisbert, K.U. Saikh, K.D. Heidebrink, P.B. Jahrling, R.G. Ulrich, and C.S. Schmaljohn Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs Virus Res. 92 2003 187 193
130. D.S. Burke, and T.P. Monath Flaviviruses D.M.K.a.P.M. Howley Fields Virology 4th Edition 2001 Lippincott Williams and Wilkins Philadelphia 1043 1109
131. T.S. Gritsun, P.A. Nuttall, and E.A. Gould Tick-borne flaviviruses Adv. Virus Res. 61 1999 317 371
132. H.J. Ehrlich, B.G. Pavlova, S. Fritsch, E.M. Poellabauer, A. Loew-Baselli, O. Obermann-Slupetzky, F. Maritsch, I. Cil, F. Dorner, and P.N. Barrett Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity Vaccine 22 2003 217 223
133. O. Zent, A. Banzhoff, A.K. Hilbert, S. Meriste, W. Sluzewski, and C. Wittermann Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer Vaccine 21 2003 3584 3592
134. O. Zent, W. Jilg, A. Plentz, T.F. Schwarz, N. Fruhwein, H.B. Kuhr, and A. Banzhoff Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule Vaccine 21 2003 4655 4660
135. R.M. Kofler, J.H. Aberle, S.W. Aberle, S.L. Allison, F.X. Heinz, and C.W. Mandl Mimicking live flavivirus immunization with a noninfectious RNA vaccine Proc. Natl. Acad. Sci. U. S. A. 101 2004 1951 1956
136. C.J. Lai, and T.P. Monath Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis Adv. Virus Res. 61 2003 469 509
137. C. Schmaljohn, L. Vanderzanden, M. Bray, D. Custer, B. Meyer, D. Li, C. Rossi, D. Fuller, J. Fuller, J. Haynes, and J. Huggins Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge J. Virol. 71 1997 9563 9569
138. F.X. Heinz, S.L. Allison, K. Stiasny, J. Schalich, H. Holzmann, C.W. Mandl, and C. Kunz Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis Vaccine 13 1995 1636 1642
139. L.C. Iacono-Connors, J.F. Smith, T.G. Ksiazek, C.L. Kelley, and C.S. Schmaljohn Characterization of Langat virus antigenic determinants defined by monoclonal antibodies to E, NS1 and preM and identification of a protective, non-neutralizing preM-specific monoclonal antibody Virus Res. 43 1996 125 136
140. C. Schmaljohn, D. Custer, L. VanderZanden, K. Spik, C. Rossi, and M. Bray Evaluation of tick-borne encephalitis DNA vaccines in monkeys Virology 263 1999 166 174
141. D.J. Gubler Dengue and dengue hemorrhagic fever Clin. Microbiol. Rev. 11 1998 480 496
142. T. Kochel, S.J. Wu, K. Raviprakash, P. Hobart, S. Hoffman, K. Porter, and C. Hayes Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice Vaccine 15 1997 547 552
143. K.R. Porter, T.J. Kochel, S.J. Wu, K. Raviprakash, I. Phillips, and C.G. Hayes Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses Arch. Virol. 143 1998 997 1003
144. K. Raviprakash, T.J. Kochel, D. Ewing, M. Simmons, I. Phillips, C.G. Hayes, and K.R. Porter Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein Vaccine 18 2000 2426 2434
145. K. Raviprakash, K.R. Porter, T.J. Kochel, D. Ewing, M. Simmons, I. Phillips, G.S. Murphy, W.R. Weiss, and C.G. Hayes Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques J. Gen. Virol. 81 2000 1659 1667
146. T.J. Kochel, K. Raviprakash, C.G. Hayes, D.M. Watts, K.L. Russell, A.S. Gozalo, I.A. Phillips, D.F. Ewing, G.S. Murphy, and K.R. Porter A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys Vaccine 18 2000 3166 3173
147. K. Raviprakash, E. Marques, D. Ewing, Y. Lu, I. Phillips, K.R. Porter, T.J. Kochel, T.J. August, C.G. Hayes, and G.S. Murphy Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF Virology 290 2001 74 82
148. Y. Lu, K. Raviprakash, I.C. Leao, P.R. Chikhlikar, D. Ewing, A. Anwar, C. Chougnet, G. Murphy, C.G. Hayes, T.J. August, and E.T. Marques Jr. Dengue 2 PreM-E/LAMP chimera targeted to the MHC class II compartment elicits long-lasting neutralizing antibodies Vaccine 21 2003 2178 2189
149. K. Raviprakash, D. Ewing, M. Simmons, K.R. Porter, T.R. Jones, C.G. Hayes, R. Stout, and G.S. Murphy Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys Virology 315 2003 345 352
150. M. Simmons, G.S. Murphy, T. Kochel, K. Raviprakash, and C.G. Hayes Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine Am. J. Trop. Med. Hyg. 65 2001 420 426
151. E. Konishi, A. Terazawa, and J. Imoto Simultaneous immunization with DNA and protein vaccines against Japanese encephalitis or dengue synergistically increases their own abilities to induce neutralizing antibody in mice Vaccine 21 2003 1826 1832
152. S.F. Wu, C.L. Liao, Y.L. Lin, C.T. Yeh, L.K. Chen, Y.F. Huang, H.Y. Chou, J.L. Huang, M.F. Shaio, and H.K. Sytwu Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice Vaccine 21 2003 3919 3929
153. G. Colombage, R. Hall, M. Pavy, and M. Lobigs DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus Virology 250 1998 151 163
154. C.H. Pan, H.W. Chen, H.W. Huang, and M.H. Tao Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses J. Virol. 75 2001 11457 11463
155. CDC Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices Morb. Mort. Wkly. Rep. 50 2002 RR-10
156. R. Blasco, and B. Moss Role of cell-associated enveloped vaccinia virus in cell-to-cell spread J. Virol. 66 1992 4170 4179
157. C.P. Czerny, S. Johann, L. Holzle, and H. Meyer Epitope detection in the envelope of intracellular naked orthopox viruses and identification of encoding genes Virology 200 1994 764 777
158. C.P. Czerny, and H. Mahnel Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies J. Gen. Virol. 71 Pt. 10 1990 2341 2352
159. M.C. Galmiche, J. Goenaga, R. Wittek, and L. Rindisbacher Neutralizing and protective antibodies directed against vaccinia virus envelope antigens Virology 254 1999 71 80
160. Y. Ichihashi, T. Takahashi, and M. Oie Identification of a vaccinia virus penetration protein Virology 202 1994 834 843
161. J.C. Ramirez, E. Tapia, and M. Esteban Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions J. Gen. Virol. 83 2002 1059 1067
162. J.F. Rodriguez, E. Paez, and M. Esteban A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers J. Virol. 61 1987 395 404
163. E.J. Wolffe, S. Vijaya, and B. Moss A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies Virology 211 1995 53 63
164. J.W. Hooper, D.M. Custer, C.S. Schmaljohn, and A.L. Schmaljohn DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge Virology 266 2000 329 339
165. J.W. Hooper, D.M. Custer, and E. Thompson Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates Virology 306 2003 181 195
166. J.W. Hooper, E. Thompson, C. Wilhelmsen, M. Zimmerman, M.A. Ichou, S.E. Steffen, C.S. Schmaljohn, A.L. Schmaljohn, and P.B. Jahrling Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox J. Virol. 78 2004 4433 4443
167. D.E. Griffin Alphaviruses D.M.K.a.P.M. Howley Fields Virology 2001 Lippincott Williams & Wilkins Philadelphia 917 949
168. J.M. Dalrymple, S. Schlesinger, and P.K. Russell Antigenic characterization of two Sindbis envelope glycoproteins separated by isoelectric focusing Virology 69 1976 93 103
169. A.M. Bennett, R.J. Phillpotts, S.D. Perkins, S.C. Jacobs, and E.D. Williamson Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus Vaccine 18 1999 588 596
170. J.L. Hooper Vaccines against hantaviruses C.S.S.a.S.T. Nichol Current Topics in Microbiology and Immunology vol. 256 2001 Sringer-Verlag Berlin, Germany 171 190
171. J.E. Smadel Epidemic hemorrhagic fever Am. J. Public Health 43 1953 1327 1330
172. R.M. Wells, J. Young, R.J. Williams, L.R. Armstrong, K. Busico, A.S. Khan, T.G. Ksiazek, P.E. Rollin, S.R. Zaki, S.T. Nichol, and C.J. Peters Hantavirus transmission in the United States Emerg. Infect. Dis. 3 1997 361 365
173. J.R. Dantas Jr., Y. Okuno, H. Asada, M. Tamura, M. Takahashi, O. Tanishita, Y. Takahashi, T. Kurata, and K. Yamanishi Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies Virology 151 1986 379 384
174. C.S. Schmaljohn, Y.K. Chu, A.L. Schmaljohn, and J.M. Dalrymple Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants J. Virol. 64 1990 3162 3170
175. D.J. McClain, P.L. Summers, S.A. Harrison, A.L. Schmaljohn, and C.S. Schmaljohn Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine J. Med. Virol. 60 2000 77 85
176. J.W. Hooper, K.I. Kamrud, F. Elgh, D. Custer, and C.S. Schmaljohn DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection Virology 255 1999 269 278
177. K.I. Kamrud, J.W. Hooper, F. Elgh, and C.S. Schmaljohn Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters Virology 263 1999 209 219
178. J.W. Hooper, D.M. Custer, E. Thompson, and C.S. Schmaljohn DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys J. Virol. 75 2001 8469 8477
179. A.K. McElroy, M. Bray, D.S. Reed, and C.S. Schmaljohn Andes virus infection of cynomolgus macaques J. Infect. Dis. 186 2002 1706 1712
180. D.M. Custer, E. Thompson, C.S. Schmaljohn, T.G. Ksiazek, and J.W. Hooper Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine J. Virol. 77 2003 9894 9905
181. M. Bharadwaj, C.R. Lyons, I.A. Wortman, and B. Hjelle Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice Vaccine 17 1999 2836 2843
182. M. Bharadwaj, K. Mirowsky, C. Ye, J. Botten, B. Masten, J. Yee, C.R. Lyons, and B. Hjelle Genetic vaccines protect against Sin Nombre hantavirus challenge in the deer mouse (Peromyscus maniculatus) J. Gen. Virol. 83 2002 1745 1751
183. A.M. Talaat, R. Lyons, and S.A. Johnston A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses Vaccine 20 2001 538 544
184. R.A. Moore, P.K. Nicholls, E.B. Santos, G.W. Gough, and M.A. Stanley Absence of canine oral papillomavirus DNA following prophylactic L1 particle-mediated immunotherapeutic delivery vaccination J. Gen. Virol. 83 2002 2299 2301
185. M.A. Stanley, R.A. Moore, P.K. Nicholls, E.B. Santos, L. Thomsen, N. Parry, S. Walcott, and G. Gough Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs Vaccine 19 2001 2783 2792
186. P. Sundaram, R.E. Tigelaar, and J.L. Brandsma Intracutaneous vaccination of rabbits with the cottontail rabbit papillomavirus (CRPV) L1 gene protects against virus challenge Vaccine 15 1997 664 671
187. T.W. Kim, C.F. Hung, D.A. Boyd, L. He, C.T. Lin, D. Kaiserman, P.I. Bird, and T.C. Wu Enhancement of DNA vaccine potency by coadministration of a tumor antigen gene and DNA encoding serine protease inhibitor-6 Cancer Res. 64 2004 400 405
188. D.L. Lodmell, M.J. Parnell, J.R. Bailey, L.C. Ewalt, and C.A. Hanlon One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination Vaccine 20 2001 838 844
189. D.L. Lodmell, M.J. Parnell, J.R. Bailey, L.C. Ewalt, and C.A. Hanlon Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers Vaccine 20 2002 2221 2228
190. R.G. Webster, E.F. Fynan, J.C. Santoro, and H. Robinson Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin Vaccine 12 1994 1495 1498
191. S. Kodihalli, J.R. Haynes, H.L. Robinson, and R.G. Webster Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin J. Virol. 71 1997 3391 3396
192. T. Kondo, M. McGregor, Q. Chu, D. Chen, T. Horimoto, and Y. Kawaoka A protective effect of epidermal powder immunization in a mouse model of equine herpesvirus-1 infection Virology 318 2004 414 419
193. B.M. Price, A.L. Liner, S. Park, S.H. Leppla, A. Mateczun, and D.R. Galloway Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein Infect. Immun. 69 2001 4509 4515
194. B.M. Price, J. Barten Legutki, D.R. Galloway, B.U. von Specht, L.B. Gilleland, H.E. Gilleland Jr., and J. Staczek Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa FEMS Immunol. Med. Microbiol. 33 2002 89 99
195. B.M. Price, D.R. Galloway, N.R. Baker, L.B. Gilleland, J. Staczek, and H.E. Gilleland Jr. Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa Infect. Immun. 69 2001 3510 3515
196. J. Staczek, L.B. Gilleland, H.C. van der Heyde, and H.E. Gilleland DNA vaccines against chronic lung infections by Pseudomonas aeruginosa FEMS Immunol. Med. Microbiol. 37 2003 147 153
197. A. Yoshida, T. Nagata, M. Uchijima, and Y. Koide Protective CTL response is induced in the absence of CD4+ T cells and IFN-gamma by gene gun DNA vaccination with a minigene encoding a CTL epitope of Listeria monocytogenes Vaccine 19 2001 4297 4306
198. S. Scheiblhofer, R. Weiss, H. Durnberger, S. Mostbock, M. Breitenbach, I. Livey, and J. Thalhamer A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses Microbes Infect. 5 2003 939 946
199. W.C. Lai, M. Bennett, S.A. Johnston, M.A. Barry, and S.P. Pakes Protection against Mycoplasma pulmonis infection by genetic vaccination DNA Cell Biol. 14 1995 643 651
200. A. Rainczuk, P.M. Smooker, L. Kedzierski, C.G. Black, R.L. Coppel, and T.W. Spithill The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol Vaccine 21 2003 3030 3042
201. R. Weiss, W.W. Leitner, S. Scheiblhofer, D. Chen, A. Bernhaupt, S. Mostbock, J. Thalhamer, and J.A. Lyon Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein Infect. Immun. 68 2000 5914 5919
202. H.J. Dean, D. Fuller, and J.E. Osorio Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis Comp. Immunol. Microbiol. Infect. Dis. 26 2003 373 388